metastatic

Latest stories

  • in Health care

    Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations

    by

    Beerse: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Commission (EC) has granted marketing authorisation for AKEEGA (niraparib and abiraterone acetate [AA]), in the form of a dual action tablet (DAT), given with prednisone or prednisolone, for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline […] More

  • in Health care

    PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients

    PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients

    by

    Researchers have found in a new research that PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients. 2-[18F]FDG-PET/CT, when used to monitor metastatic breast cancer, appears to be a stronger predictor of progression-free and disease-specific survival than conventional contrast-enhanced CT (CE-CT), says an article published in Scientific Reports. Metastatic breast […] More

  • in Health care

    Merck gets USFDA nod for Keytruda in combination with Padcev to treat Advanced or Metastatic Urothelial Cancer

    by

    Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (la/mUC) who are not eligible for cisplatin-containing chemotherapy. This […] More